Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NASDAQ: FEMY

Femasys Inc.

Healthcare | Medical - Instruments & Supplies

No licensed closing price on file for FEMY. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

Femasys Inc. (NASDAQ: FEMY) is a medical instruments and supplies company. Figures from SEC EDGAR; updated 2026-10-21 06:25 UTC.

What Femasys Inc. does

This company develops medical devices and diagnostic products focused on women's health, particularly in infertility treatment, birth control, and cervical cancer screening. Its main product, FemaSeed, delivers sperm directly to the fallopian tube as a first-step infertility treatment and has received FDA clearance and approvals in multiple countries including Canada, Europe, and Australia.

Summarized from Femasys Inc.’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

Key facts

Valuation
Return on equity-317.38%

Revenue, margins & earnings

FY2021: net loss $8M on revenue $1M$1MFY2021FY2022: net loss $11M on revenue $1M$1MFY2022FY2023: net loss $14M on revenue $1M$1MFY2023FY2024: net loss $19M on revenue $2M$2MFY2024FY2025: net loss $19M on revenue $2M$2MFY2025
  • Net income
  • Taxes & interest
  • Operating costs
  • Net loss year
Annual revenue; bands show net, operating margins · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-08-11
  • 2026-08-11DirectorStock Option (Right to Buy)Award880—
  • 2026-08-11DirectorStock Option (Right to Buy)Award880—
  • 2026-08-11Chief Operating OfficerPurchase4,375$14.0K
Sign in to see all transactions →
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →

Questions this page answers

What does Femasys Inc. do?

This company develops medical devices and diagnostic products focused on women's health, particularly in infertility treatment, birth control, and cervical cancer screening.

When did FEMY last file with the SEC?

Femasys Inc.'s most recent SEC filing on record is a 8-K filed 2026-06-24. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-21 06:25 UTC. This page is also available as JSON at /api/data?ticker=FEMY and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for FEMY and 5,000+ tickers.

Create a free account — keep FEMY
For your agent
GET /api/data?ticker=FEMY

This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt